ERASCA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 USD | -5.61% |
|
-13.55% | -13.15% |
| May. 08 | Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Chart calendar Erasca, Inc.
e2283f5591800236.D_UEFptQVRm35pxR6-OpExuiCU2hJ-nhROpf4jKF-rw.ZJczJs8AM2nzt_U4vrDaJ1mXSgDPYpugCJourHfSoNJtjEtBzQMSLO7LyQ~4e3baccbfad6eba200db120949f7601a
Upcoming events on Erasca, Inc.
Past events on Erasca, Inc.
| 2024-05-08 | Q1 2024 Earnings Release (Projected) |
| 2024-03-28 08:30 am | R&D Day |
| 2024-03-27 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-08 11:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-09 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-28 11:15 am | Evercore ISI HealthCONx Conference |
| 2023-11-15 09:30 am | Jefferies London Healthcare Conference |
| 2023-11-09 04:01 pm | Q3 2023 Earnings Release |
| 2023-09-26 08:10 am | Cantor Global Healthcare Conference |
| 2023-09-12 05:30 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-10 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-22 02:30 pm | Annual General Meeting |
| 2023-06-12 06:20 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-07 01:00 pm | Jefferies Healthcare Conference |
| 2023-06-05 04:30 pm | Business Update Call |
| 2023-06-05 04:30 pm | American Society of Clinical Oncology Conference |
| 2023-06-05 09:00 am | American Society of Clinical Oncology Conference - Abstract 3557 |
| 2023-06-05 09:00 am | American Society of Clinical Oncology Conference - Abstract 3558 |
| 2023-05-15 04:01 pm | Q1 2023 Earnings Release |
| 2023-05-09 05:20 pm | Bank of America Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -124 -129 4.06% | -245 -153 -59.96% | 0,00 -147 - | -171 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -125 -132 5.37% | -247 -152 -63% | -142 -147 3.97% | -167 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -123 -132 7.1% | -243 -145 -67.11% | -125 -127 1.5% | -147 |
|
Net income Million USD | Released Forecast Spread | -102 | -123 -133 7.41% | -243 -146 -66.87% | -125 -134 6.65% | -149 |
|
EPS USD | Released Forecast Spread | -4,84 | -1,85 -2,31 19.9% | -1,99 -1,32 -50.95% | -0,83 -0,93 10.6% | -0,95 |
| Announcement Date | 25/06/21 | 24/03/22 | 23/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBITDA Million USD | Released Forecast Spread | -36,1 -36,0 -0.28% | -35,4 -39,3 9.99% | -36,2 -38,3 5.6% | -137 -37,1 -269.28% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -36,5 -35,3 -3.44% | -35,9 -38,0 5.59% | -37,0 -37,7 2.02% | -138 -43,4 -217.83% | -37,0 -45,5 18.7% | -36,0 -38,9 7.55% | -34,7 -38,2 9.24% | -33,9 -38,2 11.38% | -38,9 -36,2 -7.36% | -40,0 | -41,3 | -42,8 | -42,0 | -43,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,5 -34,0 -7.23% | -35,6 -37,8 5.67% | -35,5 -37,8 5.99% | -135 -37,5 -260.67% | -33,2 -46,0 27.78% | -31,8 -35,1 9.54% | -30,4 -32,3 5.91% | -29,7 -30,9 3.97% | -35,0 -32,0 -9.43% | -36,1 | -37,4 | -39,1 | -39,5 | -41,0 |
|
Net income Million USD | Released Forecast Spread | -36,5 -35,1 -3.84% | -35,6 -38,2 6.73% | -35,5 -37,5 5.42% | -135 -37,5 -260.3% | -33,2 -46,0 27.78% | -31,8 -35,5 10.39% | -30,4 -32,3 5.91% | -29,7 -34,2 13.24% | -35,0 -32,1 -9.26% | -36,1 | -37,4 | -39,1 | -39,5 | -41,0 |
|
EPS USD | Released Forecast Spread | -0,31 -0,29 -5.5% | -0,30 -0,32 5.87% | -0,29 -0,31 6.45% | -1,06 -0,29 -270.49% | -0,22 -0,34 36.02% | -0,21 -0,23 10.02% | -0,20 -0,21 6.16% | -0,20 -0,23 11.32% | -0,23 -0,20 -12.58% | -0,23 | -0,24 | -0,23 | -0,25 | -0,26 |
| Announcement Date | 12/05/22 | 11/08/22 | 09/11/22 | 23/03/23 | 15/05/23 | 10/08/23 | 09/11/23 | 27/03/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Erasca, Inc.
| 2024-05-10 07:00 am | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:10 pm | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ERAS Stock
- Calendar Erasca, Inc.
